Ogren Plant Allergy Scale: Difference between revisions
CSV import |
CSV import |
||
| Line 58: | Line 58: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 21:24, 17 March 2025
Ogren Plant Allergy Scale
The Ogren Plant Allergy Scale (OPALS) is a numerical scale that measures the potential of plants to cause allergic reactions. Developed by Thomas Leo Ogren, the scale ranges from 1 to 10, with higher numbers indicating a greater likelihood of causing allergies. The scale is used by landscapers, urban planners, and individuals to select plants that are less likely to trigger allergic reactions, thereby promoting healthier environments.
Development[edit]
The OPALS was created by Thomas Leo Ogren, a horticulturist and allergy researcher, in response to the increasing prevalence of allergies and asthma. Ogren's research focused on the role of urban landscaping in exacerbating these conditions. He identified that certain plants, particularly male cultivars that produce large amounts of pollen, were significant contributors to airborne allergens.
Scale Criteria[edit]
The OPALS takes into account several factors to determine a plant's allergy potential:
- Pollen production
- Pollen potency
- Pollen size
- Pollen season length
- Plant sex (male plants typically produce more pollen)
- Plant toxicity
- Plant fragrance
- Plant sap
Each plant is evaluated based on these criteria and assigned a score from 1 to 10. Plants with scores of 1-3 are considered low-allergy, 4-6 moderate-allergy, and 7-10 high-allergy.
Applications[edit]
The OPALS is used in various fields to minimize the impact of plant allergens:
- Urban planning: To design allergy-friendly public spaces.
- Landscaping: To select plants for residential and commercial properties.
- Public health: To reduce the incidence of allergy-related health issues.
Benefits[edit]
Using the OPALS can lead to several benefits:
- Reduced incidence of allergic rhinitis and asthma.
- Improved quality of life for individuals with allergies.
- Enhanced public health outcomes.
Related Pages[edit]
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
